Aarti Drugs Limited (AARTIDRUGS) Share Analysis
NSE · Healthcare · Pharmaceuticals
Aarti Drugs Limited (NSE: AARTIDRUGS) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹507.00, P/E 20.1, ROE 13.4%.
Get the AI verdict on AARTIDRUGS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
AARTIDRUGS chart with trendlines
Is AARTIDRUGS a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Aarti Drugs Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
AARTIDRUGS key facts
| Price and valuation | |
|---|---|
| Share price | ₹507.00 |
| Market cap | ₹4,631 Cr |
| P/E ratio | 20.1 |
| P/B ratio | 2.76 |
| EPS | ₹25.08 |
| Book value per share | ₹184.00 |
| Dividend yield | 0.39% |
| 52-week range | |
| 52-week high | ₹527.50 |
| 52-week low | ₹318.95 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 54.07% |
| FIIs | 2.26% |
| DIIs | 10.24% |
| Public | 33.42% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.